Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome.
Evolving use of radiotherapy and radiosurgery in the treatment of pituitary adenomas.
Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice.
MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells.
MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells. Cell Cycle. 2013 Jun 01; 12(11):1655-6.
View in:
PubMed
subject areas
Apoptosis
Cell Line, Tumor
Humans
Naphthyridines
Neoplasms
Neoplastic Stem Cells
Neuropeptides
Phosphorylation
Proteasome Endopeptidase Complex
Protein Kinase Inhibitors
authors with profiles
Yusuke Nakamura